Health-related Quality of Life in Children with von Willebrand Disease
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Health-related quality of life in children with von Willebrand disease: results of the French real-life Willebrand Study Health-related Quality of Life study
In this nationwide French study of 117 children with all VWD types, HRQoL assessments revealed age-specific and gender-specific challenges — from physical limitations in preschoolers to independence issues in adolescents. Severe VWD and low VWF levels were linked to poorer quality of life, with notable impacts on family dynamics and treatment satisfaction.”
Read the full article here.
Article: Health-related quality of life in children with von Willebrand disease: results of the French real-life Willebrand Study Health-related Quality of Life study
Authors: Jenny Goudemand, Sophie Susen, Claire Berger, Sophie Bayart, Hervé Chambos, Fabienne Genre-Volot, Dominique Desprez, Ségolène Claeyssens, Brigitte Pan-Petesch, Annie Harroche, Laurent Ardillon, Agnès Veyradier, Malika Barthez-Toullec, Grégory Marin, Emmanuelle Lagrue, Marie Hélène André-Bonnet, Yohann Repessé, Annie Borel-Derlon, Sylvia von Mackensen
Stay updated with Hemostasis Today.
-
Aug 14, 2025, 23:47World Thrombosis Day: Know your Risk in DVT
-
Aug 14, 2025, 12:52JAMA Review: Immune Thrombotic Thrombocytopenic Purpura (iTTP)
-
Aug 14, 2025, 12:33Louise Bannon: The World Thrombosis Day Campaign is Calling on Industry Leaders
-
Aug 14, 2025, 10:58Thomas Reiser: Why October 13 Marks World Thrombosis Day?
-
Aug 14, 2025, 04:03Perioperative Thrombotic Risk Guide for Hematology Fellows
-
Aug 14, 2025, 23:47Health-related Quality of Life in Children with von Willebrand Disease
-
Aug 14, 2025, 17:54Omid Seidizadeh: From Genotype and Phenotype! Variability in Type 2 von Willebrand Disease
-
Aug 14, 2025, 17:36Samin Mohsenian: Thrombotic Paradox in Congenital Fibrinogen Deficiencies
-
Aug 14, 2025, 17:10Emmanuel J Favaloro: DOACs and Mechanical Coagulation Test Systems
-
Aug 14, 2025, 13:09Thrombin Generation Assay to Guide Factor Therapy With Fitusiran
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Aug 14, 2025, 02:08Jordan Harry's Conversation on Cancer and Clot Risk with Thrombosis Canada
-
Aug 13, 2025, 15:50Will Parsons Honors National Leaders in Hematology: Drs. Fasipe, Powers and Tubman
-
Aug 13, 2025, 10:25Joshua Muia on His HTRS Leadership Role Impact
-
Aug 11, 2025, 05:16Andreas Calatzis: Any Information on Soviet Thrombelastographs?
-
Aug 9, 2025, 15:36NBCA: Blood Clot Survivor Runs 2025 NYC Marathon with Team Stop the Clot